Lung Cancer
3rd Edition
Published on 8. January 2008
Book
Hardback
480 pages
978-1-4051-5112-2 (ISBN)
Description
Lung cancer is a major cause of cancer-related deaths in men and women. However, since the first edition of Lung Cancer was published 14 years ago, rapid progress in the biology, prevention, diagnosis, and treatment of the disease has been made.
This outstanding team from the M.D. Anderson Cancer Center takes an evidence-based approach to lung cancer management and explains these advances in depth. Comprehensive treatment guidelines are provided, the third edition of Lung Cancer explores vital issues such as:
* Lung cancer susceptibility and risk assessment
* The pathology and pathogenesis of peripheral lung adenocarcinoma including bronchioloalveolar carcinoma
* Screening for early detection
* Advances in molecular and genetic markers
* The detection and treatment of pre-neoplastic lesions and screening for lung cancer
* Novel therapies such as angiogenesis and multi-tyrosine kinase inhibitors
Lung Cancer is a concise summary of advances in lung cancer clinical research and treatment for the clinician and is an invaluable reference for respiratory physicians, medical oncologists, clinical and surgical oncologists.
Reviews / Votes
"The current edition builds on the strength of the previous editions ... .Overall, the book was well planned. Each chapter is a concise review of the recent literature, with detailed references. Where warranted, there are tables, black-and-white diagrams, and photographs that expand on the information provided in the text. This well-organized book will be useful to pulmonologists, thoracic surgeons, radiation oncologists, medical oncologists, and others with an interest in lung cancer." (New England Journal of Medicine, December 2008) "One of the most comprehensive and up-to-date treatises that I have surveyed ... .I would recommend the book highly to anyone in allied disciplines." (Doody's Book Reviews)More details
Edition
3., Auflage
Language
English
Place of publication
Chicester
United Kingdom
Publishing group
John Wiley and Sons Ltd
Target group
Professional and scholarly
medical oncologists and respiratory physicians, trainees/residents in respiratory medicine, medical oncology and clinical oncology
Edition type
Revised edition
Illustrations
illustrations
Dimensions
Height: 25 cm
Width: 20 cm
Thickness: 15 mm
Weight
666 gr
ISBN-13
978-1-4051-5112-2 (9781405151122)
Schweitzer Classification
Other editions
New editions
Jack A. Roth | Waun Ki Hong | Ritsuko U. Komaki
Lung Cancer
Book
05/2014
4th Edition
Wiley
€192.50
Shipment within 15-20 days
Additional editions
Jack A. Roth | James D. Cox | Waun Ki Hong
Lung Cancer
E-Book
08/2011
3rd Edition
Wiley-Blackwell
€151.99
Available for download
Jack A. Roth | James D. Cox | Waun Ki Hong
Lung Cancer
E-Book
04/2008
3rd Edition
Wiley-Blackwell
€151.99
Available for download
Previous edition
Jack A. Roth | James D. Cox | Waun Ki Hong
Lung Cancer
Book
04/1998
2nd Edition
Blackwell Science Inc.
€132.97
Article exhausted; check for reprint
Persons
Jack A. Roth, MD FACS, Professor and Chairman, Bud Johnson Clinical Distinguished Chair, The University of Texas M.D. Anderson Cancer Center, Department of Thoracic & Cardiovascular Surgery and Professor of Molecular and Cellular Oncology, Director, W.M. Keck Center for Cancer Gene Therapy, Houston, Texas, USA.
James D. Cox, MD, Professor and Head, Division of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Waun Ki Hong, MD, American Cancer Society Clinical Research Professor, Charles A. LeMistre Distinguished Chair in Thoracic Oncology and Professor and Chairman, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Content
Contributors.
Preface.
1 Smoking Cessation.
2 Lung Cancer Susceptibility Genes.
3 Lung Cancer Susceptibility and Risk Assessment Models.
4 The Molecular Genetics of Lung Cancer.
5 Molecular Biology of Preneoplastic Lesions of the Lung.
6 Detection of Preneoplastic Lesions.
7 Treatment of Preneoplastic Lesions of the Lung.
8 The Pathology and Pathogenesis of Peripheral Lung Adenocarcinoma Including Bronchioloalveolar Carcinoma.
9 Treatment of Bronchioloalveolar Carcinoma.
10 Molecular Profiling for Early Detection and Prediction of Response in Lung Cancer.
11 The Role for Mediastinoscopy in the Staging of Nonsmall Cell Lung Cancer.
12 Minimally Invasive Surgery for Lung Cancer.
13 Extended Resections for Lung Cancer.
14 Adjuvant Chemotherapy Following Surgery for Lung Cancer.
15 Induction Chemotherapy for Resectable Lung Cancer.
16 Image-Guided Radiation Therapy.
17 Stereotactic Body Radiation Therapy for Lung Cancer.
18 Proton Therapy.
19 Combinations of Radiation Therapy and Chemotherapy for Nonsmall Cell Lung Carcinoma.
20 New Chemotherapeutic Agents in Lung Cancer.
21 Immunologic Approaches to Lung Cancer Therapy.
22 Epidermal Growth Factor Receptor Inhibitors.
23 Tumor Angiogenesis: Biology and Therapeutic Implications for Lung Cancer.
24 Retinoids and Rexinoids in Lung Cancer Prevention and Treatment.
25 Proteasome Inhibition in Nonsmall Cell Lung Cancer Therapy.
26 Targeted Genetic Therapy for Lung Cancer.
27 Screening for Early Detection.
28 Natural Agents for Chemoprevention of Lung Cancer.
Index